| Size | Price | |
|---|---|---|
| Other Sizes |
| Targets |
(+)-Neomenthol does not have a specific pharmacological target, as it is primarily used as a flavoring and fragrance agent. It is a metabolite in the monoterpenoid biosynthesis pathway. The compound's minty aroma and cooling sensation underpin its broad use in flavor, fragrance, cosmetic, and emerging biomedical applications.
|
|---|---|
| ln Vitro |
In vitro activity of (+)-neomenthol is related to its sensory properties rather than pharmacological effects. The compound is used as a flavoring agent and fragrance ingredient. Its moderate pharmacological activity has been noted in emerging biomedical applications.
|
| ln Vivo |
In vivo activity of (+)-neomenthol is observed in its use as a flavoring agent and fragrance ingredient in various consumer products. The compound is generally recognized as safe for its intended uses in food and oral hygiene products.
|
| Enzyme Assay |
In vitro enzyme/receptor binding assays for (+)-neomenthol are not typically performed, as it is primarily a flavoring and fragrance agent rather than a pharmacologically active compound. Its interactions with sensory receptors (e.g., TRPM8) may be assessed using cell-based assays.
|
| Cell Assay |
In vitro cellular assays for (+)-neomenthol are not typically performed, as the compound is used as a flavoring and fragrance ingredient rather than as a bioactive compound tested directly on cells.
|
| Animal Protocol |
In vivo animal experiments for (+)-neomenthol are not typically performed, as the compound is a flavoring and fragrance ingredient rather than a therapeutic agent. Its safety has been established through its use in food and consumer products.
|
| ADME/Pharmacokinetics |
Pharmacokinetic data for (+)-neomenthol are limited. The compound is slightly soluble in water and soluble in alcohol and acetone. It is a liquid at room temperature and should be stored at room temperature in a cool, dark place.
|
| Toxicity/Toxicokinetics |
(+)-Neomenthol is generally recognized as safe for its intended uses as a flavoring and fragrance ingredient. The compound is not intended for therapeutic use. Standard laboratory safety precautions should be followed when handling this compound.
|
| References | |
| Additional Infomation |
D,l-Menthol is a white crystalline solid with a minty odor and taste. (NTP, 1992)
(+)-Neomenthol is a p-menthane-3-ol. (+)-Neomenthol has been reported in soft peppermint (Minthostachys mollis), Florida spearmint (Pycnanthemum floridanum), and other organisms with relevant data. (+)-Neomenthol (CAS#: 2216-52-6) has the molecular formula C10H20O and a molecular weight of 156.27. Its IUPAC name is (1S,2S,5R)-2-isopropyl-5-methylcyclohexanol. The compound is a stereoisomer of menthol found in peppermint and is used as a flavoring and fragrance agent. |
| Molecular Formula |
C10H20O
|
|---|---|
| Molecular Weight |
156.27
|
| Exact Mass |
156.151
|
| CAS # |
2216-52-6
|
| PubChem CID |
439263
|
| Appearance |
Colorless to light yellow liquid
|
| Density |
0.9±0.1 g/cm3
|
| Boiling Point |
215.4±8.0 °C at 760 mmHg
|
| Melting Point |
-22ºC(lit.)
|
| Flash Point |
93.3±0.0 °C
|
| Vapour Pressure |
0.0±0.9 mmHg at 25°C
|
| Index of Refraction |
1.457
|
| LogP |
3.2
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
1
|
| Rotatable Bond Count |
1
|
| Heavy Atom Count |
11
|
| Complexity |
120
|
| Defined Atom Stereocenter Count |
3
|
| SMILES |
CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O
|
| InChi Key |
NOOLISFMXDJSKH-UTLUCORTSA-N
|
| InChi Code |
InChI=1S/C10H20O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-11H,4-6H2,1-3H3/t8-,9+,10+/m1/s1
|
| Chemical Name |
(1S,2S,5R)-5-methyl-2-propan-2-ylcyclohexan-1-ol
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : 100 mg/mL (639.92 mM)
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 6.3992 mL | 31.9959 mL | 63.9918 mL | |
| 5 mM | 1.2798 mL | 6.3992 mL | 12.7984 mL | |
| 10 mM | 0.6399 mL | 3.1996 mL | 6.3992 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
